1. Rheumatic Heart Disease 2. Structural Heart Disease Circulatory System 1. Rheumatic Heart Disease 2. Structural Heart Disease
Conditions
Interventions
Consecutive subjects are randomly assigned to an initial evaluation with mHealth or to standard-care. Study subjects are evaluated in either one of 5-mHealth or 5-standard-care sites.
Sponsors
American Society of Echocardiography
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Symptomatic outpatients with a new or an established diagnosis of rheumatic and structural heart disease, including valvular disease, left/right ventricular failure, rheumatic valvular disease, congenital heart defects 2. Adult, pediatric, and pregnant patients 3. Patients with a prior valvuloplasty or valve replacement for structural heart disease can also be included
Exclusion criteria
Exclusion criteria: 1. Neonatal patients 2. Those with an unstable hemodynamic status
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to definitive treatment with valvuloplasty or valve replacement over 12-months is determined at the time of a healthcare encounter for valvuloplasty or valve replacement through monthly medical record review. | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of a cardiovascular hospitalization and/or death over 12-months is determined via monthly medical record review, community health worker visitation to the home, and text message follow up with the patient and care giver inquiring about a hospitalization and/or death. | — |
Countries
India
Outcome results
None listed